Dabur India Limited — Q1 FY26
Dabur's Q1 FY26 consolidated revenue grew only 1.7% YoY due to unseasonal rains impacting the seasonal portfolio (beverages, glucose).
✓ Verified against BSE filing
Did management answer the analysts?
Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.
Request to revert to earlier disclosure standards and guidance on Q2 growth.
Asked by Mihir Shah, Nomura
Management gave directional guidance but avoided a specific high-teens growth commitment.
Read the exchange
Can we request you to revert back to the earlier disclosure standards... With this ex-off seasonal impact, 7% growth that you are seeing, should one expect high-teens growth to come back from second quarter?
Last year, we did some sort of inventory correction... We will definitely expect the average growth... Beverage business will be low single-digit growth only in the coming quarter. The rest of the businesses should fire at double-digits.
Volume growth for the quarter and gross margin outlook.
Asked by Mihir Shah, Nomura
Management provided volume growth figure and margin outlook directly.
Read the exchange
Volume growth for the quarter... Gross margins continue to be under pressure... Do you foresee any headwinds on the margins?
Volume growth is low single digit, around -1%... Gross margins have not got diluted... Overall, operating margin has been maintained at the same level. For the full year, we want our operating margin to only inch up significantly.
Ad spend decline and whether base had one-offs.
Asked by Mihir Shah, Nomura
Management explained the shift from ATL to BTL and confirmed no one-offs.
Read the exchange
On the operating margin front, lastly, I see that you've been able to maintain it, but that is on the back of sharp decline in ad spends... Is there any one-off sitting in the base?
Overall, advertising and promotion expenditure has actually moved up ahead of the top line... We have redirected the money from ATL into BTL... There is no one-off sitting in the base.
Long-term growth challenges in healthcare segment post-COVID.
Asked by Prakash Kapadia, Kapadia Financial Services
Management addressed the quarter but did not fully address the long-term stagnation concern.
Read the exchange
If I were to look at the healthcare piece after the COVID base... despite all our efforts... we've not been able to cross that broader range. What are the challenges?
I don't think there's any issue of the category here... Glucose... declined by some 40%. The rest of the entire portfolio has done very well... Chyawanprash has grown by around 30%... Honey has grown by around 11%.
Growth guidance for the full year and next quarter.
Asked by Aditya Vikram, Digital Securities Private Limited
Management gave explicit growth guidance for full year and next quarter.
Read the exchange
What would be the growth guidance from here? I heard that you said beverages might not do great, but what about the other segments?
Full year, we are looking at a guidance of high single-digit kind of a growth for the full year. For the coming quarter... we should be looking at a double-digit growth.
Volume versus price growth breakup for the quarter.
Asked by Aditya Vikram, Digital Securities Private Limited
CFO provided specific volume and price numbers.
Read the exchange
In terms of this quarter performance, could you please give a breakup of volume versus price differentials?
Volume is low single digit, around -1%. Price increase is 3%, but most of it got negated... net realization was -1.8% in India.
Whether further price hikes are expected given inflation.
Asked by Aditya Vikram, Digital Securities Private Limited
Management confirmed price hikes and margin protection plans.
Read the exchange
Are you satisfied where these levels are right now, or do you see price hikes in the coming quarter?
We are seeing more inflationary pressure... we have either taken price increases... or heightened our saving initiatives... we would be able to protect our margins despite 7-8% inflation.
Strategic framework for next 2-3 years and category growth expectations.
Asked by Tejas Shah, Evindus Park
Management provided detailed strategic framework and category priorities.
Read the exchange
Is there a strategic stencil or framework you are now using to shape the next two, three years of growth? Which categories will deliver double-digit growth?
We conducted a vision exercise... seven big moves... double down on core brands... oral care, home skin care, hair care innovations... M&A in wellness.
M&A focus: new categories or premiumization of existing portfolio.
Asked by Tejas Shah, Evindus Park
Management clearly stated M&A focus on wellness and premium.
Read the exchange
When you talk about M&A, will we be going in some of the new categories... or will it be more premiumization in the existing portfolio?
We are basically looking at wellness... wellness foods, wellness health... premium, which is margin equitative to our base business.
Volume growth ex-seasonal and inventory correction status.
Asked by Gaurang Kakkar, Centrum Broking
Management gave specific volume growth and inventory status.
Read the exchange
You mentioned the volume on a reported basis is 1% degrowth... what will be the volume growth in that portfolio? Is inventory correction largely done?
Volume growth is 3% - 3.5% if you look at the 7% ex-seasonal portfolio... We don't intend to do any more inventory correction... sitting at around 21-22 days inventory.
EBITDA margin outlook for the full year.
Asked by Gaurang Kakkar, Centrum Broking
Management explicitly guided for significant margin improvement.
Read the exchange
In terms of margins... At the EBITDA front, largely, are we expecting improvement, or most of it will be reinvested in A&P and EBITDA on a full-year basis would largely be flat?
We are working towards significant improvement of operating margin as compared to last year... At this year's end, we expect operating margins to move up significantly.
Oral care outperformance and sustainability.
Asked by Alokitha Ash, Goldman Sachs
Management provided specific growth numbers and confirmed momentum.
Read the exchange
How has the toothpaste growth been much stronger than the market leader... Have there been any other initiatives... Do you expect this to continue?
Oral care category growth is around 4%. We are much substantially higher... Red franchise has grown at around 9% secondary... We expect oral care to keep firing at the same momentum.
| Claim | Management said | Filing | Verdict |
|---|---|---|---|
| Chyawanprash grew around 30% | 30% | 1.7% | Overstated vs filing |
| Honey grew around 11% | 11% | 1.7% | Overstated vs filing |
| Glucose declined by 40% | -40% | 1.7% | Understated vs filing |
| Healthcare ex-glucose grew 4.4% | 4.4% | 1.7% | Overstated vs filing |
| Full year high single-digit growth guidance | 7% | 1.7% | Overstated vs filing |
| Next quarter double-digit growth expected | 10% | 1.7% | Overstated vs filing |
Filed figures sourced from Screener.in. Claims within a small tolerance of the filing are marked “matches filing”.